Rein Therapeutics (RNTX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for August 20, 2024, to be held online at 9:00 a.m. EDT.

• Proxy materials and 2023 Annual Report are available online for review and voting.

• Shareholders are encouraged to vote electronically or request paper materials by August 9, 2024.

Voting matters and shareholder proposals

• Election of two Class I directors: Brian Windsor, Ph.D., and Alan A. Musso.

• Advisory vote to approve named executive officer compensation.

• Ratification of Marcum LLP as independent registered public accounting firm for fiscal year ending December 31, 2024.

• Board recommends voting FOR all nominees and proposals.

Board of directors and corporate governance

• Board of Directors has nominated two individuals for election as Class I directors.